- Oral presentation
- Open Access
Endoscopic third ventriculostomy (ETV) for treatment of adult hydrocephalus: long-term followup with 163 patients
Fluids and Barriers of the CNS volume 12, Article number: O8 (2015)
Treatment of specific patterns of symptomatic hydrocephalus in the adult patient may be accomplished with endoscopic third ventriculostomy (ETV) as an alternative to insertion of a ventriculoperitoneal (VP) shunt or when VP shunt failure occurs. Treatment of hydrocephalus with a VP shunt, while effective, is associated with a significant shunt failure rate that results in VP shunt revision surgery. This review examines a single center experience with ETV to treat hydrocephalus in symptomatic adult patients.
Adult patients (>/=18 years) with a diagnosis of hydrocephalus who were treated with ETV in Calgary between January 1994 and July 2014 were reviewed using a clinic database and registry. All patients were treated by one neurosurgeon.
163 adult patients with symptomatic hydrocephalus treated with ETV were identified (male=92; female=71). Mean age at the time of ETV was 46 years (range 18-83 years). 112 underwent ETV as a primary treatment and 51 patients underwent treatment after presenting with VP shunt failure (secondary ETV). 113/163 patients had a diagnosis of aqueductal stenosis, 22/163 had a diagnosis of tumor. Mean followup was 8.2 years (range 0.3-18.4 years). Symptoms in 149/163 (91.4%) of ETV patients were better or unchanged at last followup. 104/118 (88.1%) of primary ETV patients were shunt free at last followup. 39/45 (86.7%) of secondary ETV patients were shunt free at last followup.
Endoscopic (ETV) treatment of hydrocephalus is an effective longterm treatment in a select population adult patients with hydrocephalus. Outcome/results are similar for patients where ETV is used as either a primary or secondary treatment. 87-88% of patients remain shunt free with a mean 8.2 years of followup.
To understand the role of ETV for primary treatment of hydrocephalus in the adult patient.
To understand the role of ETV for secondary treatment of hydrocephalus in the adult patient.
Isaacs A M, Yuh S J, Hurlbert R J, Mitha A: Penetrating intracranial nail-gun injury to the middle cerebral artery: A successful primary repair. Surgical Neurology International. 2015, sni_178_1. Submitted
Honey C R, Yeomans W, Jayaraman J, Isaacs A, Honey C M: The Dying Art of Percutaneous Cordotomy in Canada. Journal of Palliative Medicine. 2014, 17 (5): PMID: 24717005
Paterson R Z, Parno T J, Isaacs A M, Abizaid A: Interruption of Ghrelin Signaling in the PVN Increases High-Fat Diet Intake and Body Weight in Stressed & Non-Stressed C57BL6J Male Mice. Frontiers in Neuroscience. 2013, 7 (167): PMID: 24062637
King S J, Isaacs A M, O'Farell E, Abizaid A: Motivation to Obtain Preferred Foods is Enhanced by Ghrelin in the Ventral Tegmental Area. Hormones and Behavior. 2011, 60: 572-580. 10.1016/j.yhbeh.2011.08.006. PMID: 21872601
About this article
Cite this article
Isaacs, A., Urbaneja, G. & Hamilton, M. Endoscopic third ventriculostomy (ETV) for treatment of adult hydrocephalus: long-term followup with 163 patients. Fluids Barriers CNS 12, O8 (2015). https://doi.org/10.1186/2045-8118-12-S1-O8
- Adult Patient
- Endoscopic Third Ventriculostomy
- Secondary Treatment
- Single Center Experience